Document is current

Any future updates will be listed below

New Approaches for Measurable Residual Disease Assessment in Multiple Myeloma: Integrating NGS, Mass Spectrometry, and Next-Generation Flow Cytometry to Monitor Treatment Response

Crossref DOI link: https://doi.org/10.1007/s11899-026-00771-8

Published Online: 2026-02-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark